Please login to the form below

Not currently logged in
Email:
Password:

RotaTeq

This page shows the latest RotaTeq news and features for those working in and with pharma, biotech and healthcare.

Sanofi unit takes low-cost rotavirus vaccine into phase III

Sanofi unit takes low-cost rotavirus vaccine into phase III

and Merck &Co's RotaTeq which, while effective, are still unaffordable for many countries battling with the infection. ... III trials, promising to make it available at around one-tenth the price of Rotarix and RotaTeq.

Latest news

  • GSK's Rotarix vaccine resumes use in US

    They suggested doctors use Merck's RotaTeq vaccine instead. . On Friday (May 14, 2010), the agency reversed its decision, saying there is no evidence that porcine circovirus can infect or sicken

  • Virus found in GSK's Rotarix vaccine

    Preliminary testing on Merck's RotaTeq, another rotavirus vaccine, has found no traces of PCV1.

  • WHO recommends rotavirus vaccines

    Data on Merck's rotavirus vaccine, RotaTeq, from clinical trials in Bangladesh, Vietnam, Ghana, Mali, and Kenya are expected in the autumn.

  • GSK's Rotarix protects against commonest rotaviruses

    The company has already obtained EU marketing approval. However, Merck &Co's RotaTeq was approved in the US in February 2007, and an advisory committee of the US Centers for Disease ... Control and Prevention (CDC) recently voted to recommend that all

  • Pharma news in brief

    Last month, Merck's rival Rotateq vaccine gained US Food and Drug Administration (FDA) approval as well as a Centers for Disease Control recommendation that it would be reimbursable by the

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics